Hemophilia Market to Hit USD 21.82 Billion by 2033, Driven by Gene Therapy & Rising Diagnosis | By DataM Intelligence
The hemophilia market will reach USD 21.82B by 2033, growing at 5.9% CAGR, fueled by gene therapy and recombinant factors. AUSTIN, TX, UNITED STATES, August 25, 2025 /EINPresswire.com/ -- The hemophilia market is projected to grow at a CAGR of 5.9% from …